Albert Labs International Corp. Share Price OTC Markets
Equities
ALBLF
CA0127841041
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-.--% | -.--% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 2.73M 216M |
---|---|---|---|---|---|
Net income 2021 | -1M -79.1M | Net income 2022 | -7M -554M | EV / Sales 2021 * | - |
Net cash position 2021 | 76.7K 6.07M | Net cash position 2022 | 79.12K 6.26M | EV / Sales 2022 | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-0.32
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.71% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Ravinder Kang
BRD | Director/Board Member | 58 | - |
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |
- Stock Market
- Equities
- ABRT Stock
- ALBLF Stock